Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Thrombotic microangiopathy in transplantation and malignancy.

Qu L, Kiss JE.

Semin Thromb Hemost. 2005 Dec;31(6):691-9. Review.

PMID:
16388420
2.

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E, Ho V, Lee SJ, Soiffer R, Antin JH.

Biol Blood Marrow Transplant. 2005 Jul;11(7):551-7.

3.

Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.

Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA, Wei C, Anderlini P, Popat U, Shpall E, Giralt S, Champlin RE.

Biol Blood Marrow Transplant. 2007 Apr;13(4):469-77. Epub 2007 Feb 8.

4.

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.

Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M.

Am J Hematol. 2006 Jul;81(7):525-31.

5.

Thrombotic microangiopathy following bone marrow transplantation.

Pettitt AR, Clark RE.

Bone Marrow Transplant. 1994 Oct;14(4):495-504. Review.

PMID:
7858524
6.

Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, Morreale G, Lanino E, Annaloro C, Volpe AD, Alessandrino P, Longoni D, Locatelli F, Sangalli H, Rovelli A.

Transplantation. 2006 Sep 15;82(5):638-44.

PMID:
16969286
7.

Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.

Mii A, Shimizu A, Masuda Y, Fujino T, Kaneko T, Utsumi K, Arai T, Ishikawa A, Wakamatsu K, Tajika K, Iino Y, Katayama Y, Fukuda Y.

Pathol Int. 2011 Jan;61(1):34-41. doi: 10.1111/j.1440-1827.2010.02608.x. Epub 2010 Nov 5.

PMID:
21166941
8.

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.

Shimoni A, Yeshurun M, Hardan I, Avigdor A, Ben-Bassat I, Nagler A.

Biol Blood Marrow Transplant. 2004 Jul;10(7):484-93.

9.

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.

Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport AP, Cottler-Fox M, Tricot G, Ruehle K, Meisenberg B.

Transfusion. 2003 Jan;43(1):78-84.

PMID:
12519434
10.

[Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease].

Hirabayashi N.

Rinsho Ketsueki. 2000 Jun;41(6):491-5. Review. Japanese. No abstract available.

PMID:
10921348
11.

Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation.

Narimatsu H, Kami M, Hara S, Matsumura T, Miyakoshi S, Kusumi E, Kakugawa Y, Kishi Y, Murashige N, Yuji K, Masuoka K, Yoneyama A, Wake A, Morinaga S, Kanda Y, Taniguchi S.

Bone Marrow Transplant. 2005 Sep;36(6):517-23.

PMID:
16025150
12.

Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.

Kojouri K, George JN.

Curr Opin Oncol. 2007 Mar;19(2):148-54. Review.

PMID:
17272988
13.

Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation.

Teruya J, Styler M, Verde S, Topolsky D, Crilley P.

J Clin Apher. 2001;16(4):169-74. Review.

PMID:
11835412
14.

Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.

Kennedy GA, Kearey N, Bleakley S, Butler J, Mudie K, Durrant S.

Bone Marrow Transplant. 2010 Apr;45(4):699-704. doi: 10.1038/bmt.2009.233. Epub 2009 Sep 21.

PMID:
19767787
15.

Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.

Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y.

Bone Marrow Transplant. 2004 Jun;33(11):1143-50.

PMID:
15077133
17.

Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease.

Ishikawa Y, Nishio S, Sasaki H, Kudo R, Goto H, Ito M, Suzuki A, Fukazawa Y, Mochizuki T, Koike T.

Clin Exp Nephrol. 2011 Feb;15(1):179-83. doi: 10.1007/s10157-010-0376-y. Epub 2010 Dec 1.

PMID:
21120571
18.

[Thrombotic microangiopathy after kidney transplantation].

Basić-Jukić N, Jurić I, Brunetta-Gavranić B, Kes P, Bubić-Filipi L, Glavas-Boras S.

Acta Med Croatica. 2008;62 Suppl 1:93-6. Croatian.

PMID:
18578340
19.

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

Batts ED, Lazarus HM.

Bone Marrow Transplant. 2007 Oct;40(8):709-19. Epub 2007 Jul 2. Review.

PMID:
17603513
20.

Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.

García-Martín P, Alarcón-Payer C, López-Fernández E, Moratalla L, Romero A, Sainz J, Ríos R, Jurado M.

Ann Pharmacother. 2015 Sep;49(9):986-94. doi: 10.1177/1060028015593369. Epub 2015 Jul 9.

PMID:
26160968

Supplemental Content

Support Center